Monthly archive | PharmaTutor

29 May 2016

Recruitment for Chemists in TSGENCO - 42 posts

Telangana State Power Generation Corporation Limited (TSGENCO) is one of the pivotal organizations of Telangana State, engaged in the generation of power with an installed capacity of 5045.6 MW. It has also taken-up vast expansion of existing Power Generating Stations and also undertaken new Power Projects to supply quality and quantity power at an affordable cost, invites applications from the eligible and qualified candidates for the post of Chemist

Post- Chemist-(42 Post)

29 May 2016

PharmaQuiz- 47 | Find answers of PharmaQuiz - 46

ANSWERS of Previous PharmaQUIZ - 46

1.B 2.D 3.A 4.C 5.B

6.C 7.C 8.D 9.B 10.B

SEE QUESTIONS OF QUIZ - 46

29 May 2016

Vacancy as Team Member - Peptide Production in Mylan

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 16,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.

Post: Team Member - Peptide Production - 16000507

29 May 2016

Opportunity to work as Stability Integrator/Owner in Johnson & Johnson

Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products.In India, Johnson & Johnson operates as a single legal entity and consists of the 3 strategic business units: Consumer Products, Pharmaceuticals and Medical Devices which are independently managed and report into their respective Global business segments.

Post: Stability Integrator/Owner

29 May 2016

Career as Team Leader/Associate Manager in Novo Nordisk-B.Pharm/B.Sc/B.Tech

Novo nordisk's data management department was established in Bangalore, India in the month of September 2007 and has significantly grown from 10 members to a strong team of over 140 Clinical Data Management professionals. It has witnessed significant transformations right from providing DM services to IO region reporting to IOCDC to becoming an integral part of Global development from Aug 2010. It is a young, enthusiastic and dynamic team with varied skillsets and professionals from diverse backgrounds such as pharmacy, life-sciences, physiotherapy, computer / information sciences and business administration.

Post: Team Leader/Associate Manager

Read more about AstraZeneca receives CRL from US FDA for sodium zirconium cyclosilicate (ZS-9)

AstraZeneca announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for sodium zirconium cyclosilicate (ZS-9), the investigational medicine being developed for the treatment of hyperkalaemia (high potassium level in the blood serum) by ZS Pharma, a wholly-owned subsidiary of AstraZeneca.

Read more about FDA Approve Biogen and AbbVie’s Once-Monthly ZINBRYTA

The U.S. Food and Drug Administration (FDA) approved ZINBRYTATM (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS), Biogen and Abbvie announced. Because of its safety profile, the use of ZINBRYTA should generally be reserved for patients who have had an inadequate response to two or more therapies indicated for the treatment of multiple sclerosis (MS).

Read more about FDA approves Axumin, a new diagnostic imaging agent to detect recurrent prostate cancer

The U.S. Food and Drug Administration approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment. Axumin is marketed by Blue Earth Diagnostics, Ltd., Oxford, United Kingdom

Read more about FDA Approves Braeburn Pharmaceutical’s Probuphine Implant

Braeburn Pharmaceuticals announces that the U.S. Food & Drug Administration (FDA) approved Probuphine, the first implant for the maintenance treatment of opioid dependence in patients who have sustained clinical stability on low-to-moderate doses of buprenorphine, specifically 8 mg or less per day. Probuphine delivers buprenorphine continuously for up to six months and should be used as part of a complete treatment program to include counseling and psychosocial support.

28 May 2016

Work as Team Member - Quality Assurance in Mylan

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 16,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.

Post: Team Member - Quality Assurance-16000533

Search

May 2016

Recruitment for Chemists in TSGENCO - 42 posts

RECOMMENDED POSTS

Subscribe with us

Jobs by Category